Sphingosine 1-phosphate

Sphingosine 1-phosphate is a lipid of Sphingolipids (SP) class. Sphingosine 1-phosphate is associated with abnormalities such as Infection, Painful Bladder Syndrome, Atherosclerosis, Hyperglycemia and Rheumatoid Arthritis. The involved functions are known as Phosphorylation, Regulation, enzyme activity, Energy Absorption and Vascular Permeability. Sphingosine 1-phosphate often locates in Endothelium, Tissue membrane, Vascular System, Protoplasm and Microfilaments. The associated genes with Sphingosine 1-phosphate are MBTPS1 gene, FBXL15 gene, TEK gene, NTRK1 gene and Gene Family. The related lipids are Promega, Lipopolysaccharides, lysophosphatidic acid, Lysophosphatidylcholines and Lysophospholipids. The related experimental models are Knock-out, Mouse Model, Transgenic Model, Disease model and Experimental Autoimmune Encephalomyelitis.

Cross Reference

Introduction

To understand associated biological information of Sphingosine 1-phosphate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Sphingosine 1-phosphate?

Sphingosine 1-phosphate is suspected in Lymphopenia, Ischemia, Infection, Atherosclerosis, Multiple Sclerosis, Asthma and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Sphingosine 1-phosphate

MeSH term MeSH ID Detail
Diabetes Mellitus, Experimental D003921 85 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetic Angiopathies D003925 20 associated lipids
Diabetic Nephropathies D003928 39 associated lipids
Dilatation, Pathologic D004108 5 associated lipids
Edema D004487 152 associated lipids
Encephalomyelitis, Autoimmune, Experimental D004681 26 associated lipids
Eye Abnormalities D005124 7 associated lipids
Fibrosis D005355 23 associated lipids
Per page 10 20 50 100 | Total 101

PubChem Associated disorders and diseases

What pathways are associated with Sphingosine 1-phosphate

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Sphingosine 1-phosphate through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Sphingosine 1-phosphate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Sphingosine 1-phosphate?

Knock-out

Knock-out are used in the study 'Sphingosine 1-phosphate-dependent trafficking of peritoneal B cells requires functional NFkappaB-inducing kinase in stromal cells.' (Kunisawa J et al., 2008), Knock-out are used in the study 'Connective tissue growth factor (CTGF/CCN2) mediates angiogenic effect of S1P in human dermal microvascular endothelial cells.' (Markiewicz M et al., 2011), Knock-out are used in the study 'Chasing sphingosine-1-phosphate, a lipid mediator for cardiomyocyte survival.' (Yang Q, 2007), Knock-out are used in the study 'Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function.' (Idzko M et al., 2006) and Knock-out are used in the study 'Platelet endothelial cell adhesion molecule-1 modulates endothelial cell motility through the small G-protein Rho.' (Gratzinger D et al., 2003).

Mouse Model

Mouse Model are used in the study 'Regulation of the micromechanical properties of pulmonary endothelium by S1P and thrombin: role of cortactin.' (Arce FT et al., 2008), Mouse Model are used in the study 'Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis.' (Tengood JE et al., 2010), Mouse Model are used in the study 'S1P(5) is required for sphingosine 1-phosphate-induced autophagy in human prostate cancer PC-3 cells.' (Chang CL et al., 2009), Mouse Model are used in the study 'Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages.' (Hughes JE et al., 2008) and Mouse Model are used in the study 'The alliance of sphingosine-1-phosphate and its receptors in immunity.' (Rivera J et al., 2008).

Transgenic Model

Transgenic Model are used in the study 'Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.' (Augé N et al., 2004), Transgenic Model are used in the study 'Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration.' (Sabbadini RA, 2011) and Transgenic Model are used in the study 'Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy.' (Gault CR and Obeid LM, 2011).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Sphingosine 1-phosphate

Download all related citations
Per page 10 20 50 100 | Total 2896
Authors Title Published Journal PubMed Link
Okamoto H et al. EDG3 is a functional receptor specific for sphingosine 1-phosphate and sphingosylphosphorylcholine with signaling characteristics distinct from EDG1 and AGR16. 1999 Biochem. Biophys. Res. Commun. pmid:10381367
Mazurek N et al. Regulatory effect of phorbol esters on sphingosine kinase in BALB/C 3T3 fibroblasts (variant A31): demonstration of cell type-specific response--a preliminary note. 1994 Biochem. Biophys. Res. Commun. pmid:8292009
Osada M et al. Enhancement of sphingosine 1-phosphate-induced migration of vascular endothelial cells and smooth muscle cells by an EDG-5 antagonist. 2002 Biochem. Biophys. Res. Commun. pmid:12445827
Li QF et al. Sphingosine 1-phosphate induces Mcl-1 upregulation and protects multiple myeloma cells against apoptosis. 2008 Biochem. Biophys. Res. Commun. pmid:18423379
Betito S and Cuvillier O Regulation by sphingosine 1-phosphate of Bax and Bad activities during apoptosis in a MEK-dependent manner. 2006 Biochem. Biophys. Res. Commun. pmid:16414356
Krump-Konvalinkova V et al. FTY720 inhibits S1P-mediated endothelial healing: relationship to S1P1-receptor surface expression. 2008 Biochem. Biophys. Res. Commun. pmid:18402775
Czech B et al. The immunomodulatory sphingosine 1-phosphate analog FTY720 reduces lesion size and improves neurological outcome in a mouse model of cerebral ischemia. 2009 Biochem. Biophys. Res. Commun. pmid:19720050
Hiraga Y et al. Changes in S1P1 and S1P2 expression during embryonal development and primitive endoderm differentiation of F9 cells. 2006 Biochem. Biophys. Res. Commun. pmid:16631609
Kang JW and Lee SM Impaired expression of caveolin-1 contributes to hepatic ischemia and reperfusion injury. 2014 Biochem. Biophys. Res. Commun. pmid:24997335
Viswanathan P et al. Differential elastic responses to barrier-altering agonists in two types of human lung endothelium. 2016 Biochem. Biophys. Res. Commun. pmid:27473658
Tang HB et al. S1P/S1PR3 signaling mediated proliferation of pericytes via Ras/pERK pathway and CAY10444 had beneficial effects on spinal cord injury. 2018 Biochem. Biophys. Res. Commun. pmid:29534963
Lee OH et al. Sphingosine 1-phosphate stimulates tyrosine phosphorylation of focal adhesion kinase and chemotactic motility of endothelial cells via the G(i) protein-linked phospholipase C pathway. 2000 Biochem. Biophys. Res. Commun. pmid:10652210
Hu W et al. Lentiviral siRNA silencing of sphingosine-1-phosphate receptors S1P1 and S1P2 in smooth muscle. 2006 Biochem. Biophys. Res. Commun. pmid:16574065
Sato C et al. Sphingosine 1-phosphate receptor activation enhances BMP-2-induced osteoblast differentiation. 2012 Biochem. Biophys. Res. Commun. pmid:22659743
Kim BS et al. The sphingosine-1-phosphate derivative NHOBTD inhibits angiogenesis both in vitro and in vivo. 2011 Biochem. Biophys. Res. Commun. pmid:21888894
Wong RC et al. Gap junctions modulate apoptosis and colony growth of human embryonic stem cells maintained in a serum-free system. 2006 Biochem. Biophys. Res. Commun. pmid:16616002
Yu FC et al. Protective effect of sphingosine-1-phosphate for chronic intermittent hypoxia-induced endothelial cell injury. 2018 Biochem. Biophys. Res. Commun. pmid:29550481
Alden KP et al. Sphingolipid long chain base phosphates can regulate apoptotic-like programmed cell death in plants. 2011 Biochem. Biophys. Res. Commun. pmid:21683064
Benamer N et al. Electrophysiological and functional effects of sphingosine-1-phosphate in mouse ventricular fibroblasts. 2011 Biochem. Biophys. Res. Commun. pmid:21420933
Cheon S et al. Sphingosine kinase inhibitor suppresses IL-18-induced interferon-gamma production through inhibition of p38 MAPK activation in human NK cells. 2008 Biochem. Biophys. Res. Commun. pmid:18602364
Sun HY et al. Sphingosine-1-phosphate induces human endothelial VEGF and MMP-2 production via transcription factor ZNF580: novel insights into angiogenesis. 2010 Biochem. Biophys. Res. Commun. pmid:20382120
Sato K et al. HDL-like lipoproteins in cerebrospinal fluid affect neural cell activity through lipoprotein-associated sphingosine 1-phosphate. 2007 Biochem. Biophys. Res. Commun. pmid:17544365
Liu R et al. Effects of sphingosine derivatives on MC3T3-E1 pre-osteoblasts: psychosine elicits release of calcium from intracellualr stores. 1995 Biochem. Biophys. Res. Commun. pmid:7677781
Park KS et al. S1P stimulates chemotactic migration and invasion in OVCAR3 ovarian cancer cells. 2007 Biochem. Biophys. Res. Commun. pmid:17349972
Kawata T et al. Sphingosine 1-phosphate inhibits migration and RANTES production in human bronchial smooth muscle cells. 2005 Biochem. Biophys. Res. Commun. pmid:15850807
Hutami IR et al. Fas/S1P crosstalk via NF-κB activation in osteoclasts controls subchondral bone remodeling in murine TMJ arthritis. 2017 Biochem. Biophys. Res. Commun. pmid:28687489
Ignatov A et al. Sphingosine-1-phosphate is a high-affinity ligand for the G protein-coupled receptor GPR6 from mouse and induces intracellular Ca2+ release by activating the sphingosine-kinase pathway. 2003 Biochem. Biophys. Res. Commun. pmid:14592418
Separovic D et al. Combining anticancer agents photodynamic therapy and LCL85 leads to distinct changes in the sphingolipid profile, autophagy, caspase-3 activation in the absence of cell death, and long-term sensitization. 2011 Biochem. Biophys. Res. Commun. pmid:21545791
Bayless KJ and Davis GE Sphingosine-1-phosphate markedly induces matrix metalloproteinase and integrin-dependent human endothelial cell invasion and lumen formation in three-dimensional collagen and fibrin matrices. 2003 Biochem. Biophys. Res. Commun. pmid:14651957
Morii T and Weissbach L Sphingosine 1-phosphate and cell migration: resistance to angiogenesis inhibitors. 2003 Biochem. Biophys. Res. Commun. pmid:14550287
Lin CI et al. Sphingosine 1-phosphate regulates inflammation-related genes in human endothelial cells through S1P1 and S1P3. 2007 Biochem. Biophys. Res. Commun. pmid:17331465
Bjursell M et al. G protein-coupled receptor 12 deficiency results in dyslipidemia and obesity in mice. 2006 Biochem. Biophys. Res. Commun. pmid:16887097
Bandhuvula P et al. Sphingosine 1-phosphate lyase enzyme assay using a BODIPY-labeled substrate. 2009 Biochem. Biophys. Res. Commun. pmid:19250638
Hamada K et al. Involvement of Mac-1-mediated adherence and sphingosine 1-phosphate in survival of phorbol ester-treated U937 cells. 1998 Biochem. Biophys. Res. Commun. pmid:9535736
Rahman MM et al. Secretion of PDGF isoforms during osteoclastogenesis and its modulation by anti-osteoclast drugs. 2015 Biochem. Biophys. Res. Commun. pmid:25951977
Ikeda H et al. Sphingosine 1-phosphate enhances portal pressure in isolated perfused liver via S1P2 with Rho activation. 2004 Biochem. Biophys. Res. Commun. pmid:15240112
Al Alam N and Kreydiyyeh SI FTY720P inhibits hepatic Na(+)-K(+) ATPase via S1PR2 and PGE2. 2016 Biochem. Cell Biol. pmid:27501354
Wang F et al. Sphingosine 1-phosphate stimulates rho-mediated tyrosine phosphorylation of focal adhesion kinase and paxillin in Swiss 3T3 fibroblasts. 1997 Biochem. J. pmid:9182707
Cho H et al. The aorta and heart differentially express RGS (regulators of G-protein signalling) proteins that selectively regulate sphingosine 1-phosphate, angiotensin II and endothelin-1 signalling. 2003 Biochem. J. pmid:12564955
Ghelli A et al. Phospholipase D1 is threonine-phosphorylated in human-airway epithelial cells stimulated by sphingosine-1-phosphate by a mechanism involving Src tyrosine kinase and protein kinase Cdelta. 2002 Biochem. J. pmid:12014986
Purschke WG et al. Identification and characterization of a mirror-image oligonucleotide that binds and neutralizes sphingosine 1-phosphate, a central mediator of angiogenesis. 2014 Biochem. J. pmid:24832383
Venkataraman K et al. Extracellular export of sphingosine kinase-1a contributes to the vascular S1P gradient. 2006 Biochem. J. pmid:16623665
Schnute ME et al. Modulation of cellular S1P levels with a novel, potent and specific inhibitor of sphingosine kinase-1. 2012 Biochem. J. pmid:22397330
Meacci E et al. Sphingosine 1-phosphate evokes calcium signals in C2C12 myoblasts via Edg3 and Edg5 receptors. 2002 Biochem. J. pmid:11853542
Kiss Z et al. Extracellular sphingosine 1-phosphate stimulates formation of ethanolamine from phosphatidylethanolamine: modulation of sphingosine 1-phosphate-induced mitogenesis by ethanolamine. 1997 Biochem. J. pmid:9371692
Inagaki Y et al. Sphingosine 1-phosphate analogue recognition and selectivity at S1P4 within the endothelial differentiation gene family of receptors. 2005 Biochem. J. pmid:15733055
Eggerickx D et al. Molecular cloning of an orphan G-protein-coupled receptor that constitutively activates adenylate cyclase. 1995 Biochem. J. pmid:7639700
Banno Y et al. Involvement of phospholipase D in insulin-like growth factor-I-induced activation of extracellular signal-regulated kinase, but not phosphoinositide 3-kinase or Akt, in Chinese hamster ovary cells. 2003 Biochem. J. pmid:12385647
Lynch KR Building a better sphingosine kinase-1 inhibitor. 2012 Biochem. J. pmid:22533672
Yamaguchi H et al. Sphingosine-1-phosphate receptor subtype-specific positive and negative regulation of Rac and haematogenous metastasis of melanoma cells. 2003 Biochem. J. pmid:12803545